Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP "
Press Release Feb 24 2026
Filed with NSE · · 3 pages · English
Release
Caplin Point Laboratories Limited on 6ix
Earlier from Caplin Point Laboratories
- Press Release Jan 27 2026
- Press Release Oct 23 2025
- Press Release Sep 03 2025
- Press Release May 14 2025
- Press Release Apr 23 2025
Later from Caplin Point Laboratories
- Press Release Feb 28 2026
- Press Release Mar 13 2026
- Press Release May 05 2026
- Press Release May 14 2026
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories